Swansea's Former Woolworths Building at Centre of £3m Research Project
The project, Retrofitting for the Future: Nature-Based Solutions for Climate Adaptation, brings together a consortium of academic and societal partners to explore how biophilic design – working with nature rather than against it – can help urban areas adapt to the intensifying impacts of climate change.
The four-year transdisciplinary project, which is one of only three selected across the UK through the AHRC's new Mission Awards, will investigate how older urban buildings and public spaces can be reimagined as sustainable, liveable places that promote human and ecological well-being.
The project's flagship case study is the transformation of Swansea's former Woolworths building, now The Biome, into the UK's first retrofitted 'living building', integrating housing, commercial, community and education spaces with nature at its core.
Dr Jeremy Smith, Dean of the Institute of Education and Humanities from University of Wales Trinity Saint David, said:
'This award reflects the bold, collaborative thinking required to address the climate and nature emergencies. I'm especially proud of UWTSD's leadership in this work, which brings the arts, humanities, and sciences together with civic and community partners to explore how we can make urban life healthier, greener and more resilient. This is not only about buildings – it's about people, place, and the futures we're building together.'
The research team at UWTSD will lead key strands of the project focusing on the cultural, social, ecological, and policy dimensions of biophilic retrofitting. Working in close collaboration with industry, housing, health, education and policy partners, the team will identify and overcome the technical, regulatory and behavioural barriers that hinder the adoption of nature-based solutions in cities.
Dr Luci Attala, Deputy Executive Director of the UNESCO-MOST BRIDGES global coalition and Associate Professor in Anthropology at UWTSD, added:
'Retrofitting for the Future aligns with Wales's Well-being of Future Generations Act and the UN's Sustainable Development Goals. We urgently need to rethink the way we live in cities not just structurally, but emotionally and ecologically. Our research is grounded in co-creation and lived experience, ensuring that the voices of residents, creatives, and communities shape the future of urban living. This project offers a blueprint for how we can retrofit not just our buildings, but our relationships with nature, each other, and the systems that govern us.'
The consortium includes University College London, Swansea University, Hacer Developments, Pobl Group, Natural Resources Wales, and the City and County of Swansea Council, along with a range of local and international partners.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
Lung cancer warning for foods which make up ‘half the average diet' after new study
Ultra-processed foods filled with preservatives, additives and flavour enhancers have been linked to an increased risk of lung cancer. In the UK and US, more than half of the average diet consists of ultra-processed foods (UPFs), such as ready meals, fast food and fizzy drinks. A previous BMJ study in 2024 linked UPFs to 32 harmful health effects including a higher risk of heart disease, cancer, type 2 diabetes, adverse mental health and early death. Now, eating UPFs has been linked to lung cancer - the most common cancer in the world, according to the World Cancer Research Fund. There were an estimated 2.2 million new cases and 1.8 million deaths from the disease worldwide in 2020, researchers of the study published in the respiratory journal Thorax said. But limiting consumption of these foods may help curb the global impact of the disease, the researchers say. Although there is no exact definition of a UPF, these foods typically undergo multiple processing steps, contain long lists of additives and preservatives, and are ready-to-eat or heat. Researchers drew on data from the US Prostate, Lung, Colorectal and Ovarian Cancer Screening Trials, involving 155,000 participants aged 55 to 74 who were randomly assigned to either a screening or comparison group between November 1993 and July 2001. Cancer diagnoses were tracked until the end of 2009, and cancer deaths until the end of 2018. A total of 101,732 people (50,187 men and 51,545 women, with an average age of 62) who completed a questionnaire on their dietary habits upon entry to the trials were included in the study. Foods were categorised as: unprocessed or minimally processed; containing processed culinary ingredients; processed; or ultra-processed. The researchers focused in particular on UPFs that included sour cream, as well as cream cheese, ice cream, frozen yoghurt, fried foods, bread, baked goods, salted snacks, breakfast cereals, instant noodles, shop-bought soups and sauces, margarine, confectionery, soft drinks, sweetened fruit drinks, restaurant/shop-bought hamburgers, hot dogs, and pizza. The three types of food that featured the most were lunch meat (11 per cent), diet or caffeinated soft drinks (just over 7 per cent) and decaffeinated soft drinks (nearly 7 per cent). Participants were tracked for 12 years and in that time, 1,706 new cases of lung cancer were diagnosed, including 1,473 cases of non-small cell lung cancer (NSCLC) and 233 of small cell lung cancer (SCLC). After accounting for potentially influential factors, including smoking and overall diet quality, participants who ate the most UPFs were 41 per cent more likely to be diagnosed with lung cancer than those who ate the least. Overall, they were 37 per cent more likely to be diagnosed with NSCLC and 44 per cent more likely to be diagnosed with SCLC. Because it was an observational study and no firm conclusions can be drawn about cause and effect, researchers acknowledge that they weren't able to factor in smoking intensity, which may have been influential. Dietary information was collected only once, so they could not account for changes over time, and the number of cancer diagnoses was small. But researchers do highlight the low nutritional value of UPFs and the excessive amounts of salt, sugar and fats they contain. 'The rise in UPF consumption may have driven global increases in obesity, cardiovascular disease, metabolic disorders, cancer and mortality, as these foods are confirmed risk factors for such conditions,' the researchers suggested. 'Industrial processing alters the food matrix, affecting nutrient availability and absorption, while also generating harmful contaminants,' they added, highlighting acrolein, which is found in grilled sausages and caramel sweets and is a toxic component of cigarette smoke. Packaging materials may also have a role to play, they suggested. 'You can't say from this study that UPFs cause cancer as it's observational, so we're looking at associations, not direct effects. But it does strengthen the case for looking more closely at the food environment many people are living in where UPFs are cheap, convenient, and heavily marketed, making them a go-to for many,' Rob Hobson, nutritionist and author of Unprocess Your Family Life, told The Independent. He suggested, rather than 'pointing figures at individual foods', to instead make small shifts towards a healthier diet. 'That might mean cooking more from scratch where possible, adding in more whole foods like vegetables, beans and grains, or just becoming more aware of how often UPFs show up in your day,' he said. 'It's not about being perfect, it's about balance and understanding how your food choices could be supporting or undermining your long-term health.'
The Sun
an hour ago
- The Sun
Common medicines may not work for some people based on their DNA, experts find
A PILOT scheme has revealed a widespread genetic sensitivity to common medicines which could increase side effects or stop them working as they should. The trial saw 2,200 adults undergo whole genome sequencing to analyse how their individual DNA responds to the likes of antibiotics and over the counter painkillers. 1 A staggering 99 per cent showed a genetic variant that affects their sensitivity to certain medicines. This could mean some drugs, including over the counter, everyday painkillers, antibiotics and other prescription medications, won't work for some people based on their individual DNA. The blood test, part of Bupa's My Genomic Health scheme, also looked their genetic risk of developing 36 preventable diseases including cancers, heart conditions and type 2 diabetes. It found 91 per cent of participants were found to be at risk of developing a disease with genetic and lifestyle risk factors, such as fatty liver disease, breast cancer and certain heart diseases. While 73 per cent had multiple genetic variants that put them at raised risk of developing a condition that could be prevented or detected early, leading to better health outcomes, including the likes of high cholesterol, skin cancer and type 2 diabetes. And 49 per cent were found to be carriers of a genetic variant that could lead to raised risk of certain condition in future generations. Following the successful pilot, Medication Check can now be purchased through Bupa, and will also be available to more than three million its customers as part of its workplace health scheme. A saliva test will establish what medications are most likely to be effective, those with increased risk of adverse side effects, or ones that won't work for them at all. Dr Rebecca Rohrer, clinical innovation and genomics director for Bupa, said: 'We've long known that most medications only work for 30-50 per cent of the population. 'However, this pilot has highlighted just how significantly individual genomes impact the effectiveness of medications in treating conditions. Beware 3 of the most dangerous medicines in the world - including one found in almost EVERY home 'With more than half of us regularly taking a prescription medication and an increasing number affected by a chronic condition, it's crucial that people are prescribed the right medicine from the start, tailored to their unique genetic makeup. 'In the longer term, genomics is key to early detection and even preventing some illnesses altogether.' After completing the at-home medication check, patients will be offered a GP consultation with the healthcare provider to review any medication identified in their genetic tests. It comes as Bupa is about to introduce two new products to its My Genomic Health suite later this year, that will help to prevent or detect illness earlier. The DNA Health Check will give people early warning of an increased genetic risks of four different conditions - breast cancer, prostate cancer, type 2 diabetes and cardiovascular disease. While the Advanced DNA Health Check will combine insights from medication, disease risk, carrier status and traits, and will look at the genetic risk of developing conditions such as heart disease, metabolic disease and 10 types of cancer. Carlos Jaureguizar, CEO for Bupa Global, India & UK, said: 'Whole genomic sequencing is fundamentally changing our approach to healthcare, pivoting from treatment to prevention. 'It has the power to become a health passport that people can reference throughout their lives. 'We firmly believe genomics is the path to health innovation and prevention, reducing the nation's health burden and giving people personalised knowledge of their own genomic profile to live well for longer.'
Medical News Today
3 hours ago
- Medical News Today
Dementia may take 3.5 years to diagnose after symptoms begin, but why?
Dementia is a hard disease to diagnose for a number of reasons.A new study has found that people who have dementia are, on average, diagnosed 3.5 years after symptoms first appear. This is even longer — an average of 4.1 years after symptoms first show — for people with early onset dementia. According to the World Health Organization (WHO), about 57 million people around the world in 2021 were living with dementia — an umbrella term for a group of conditions that impact a person's memory and ability to think and communicate, such as Alzheimer's disease. Dementia is a hard disease to diagnose. There is currently no single test to diagnose the condition, and symptoms of dementia are very similar to those of other diseases. Additionally, for some people, their dementia symptoms are very subtle in the early stage of the disease, making it hard for a doctor to make a complete diagnosis. Over the last few years, researchers have been focusing on finding new ways to help doctors detect and diagnose dementia as early as possible. 'Timely diagnosis of dementia is crucial for several reasons,' Vasiliki Orgeta, PhD, associate professor in the Division of Psychiatry, Faculty of Brain Sciences at University College London, explained to Medical News Today. 'First and foremost, early detection empowers individuals and their families to plan ahead, and make informed decisions about their care.' 'From a healthcare perspective, timely diagnosis reduces the strain on healthcare systems by enabling proactive rather than reactive care,' she continued. 'As our global population ages, the prevalence of dementia is rising sharply. Timely diagnosis, therefore, is key to addressing this growing public health challenge.' Orgeta is the lead author of a new study recently published in the International Journal of Geriatric Psychiatry that reports people who have dementia are, on average, diagnosed 3.5 years after symptoms first appear. This is even longer — an average of 4.1 years after symptoms first show — for people with early onset dementia. The time between symptoms and dementia diagnosisFor this study, researchers analyzed the results of 13 previously published studies, encompassing more than 30,000 participants. Scientists focused on the average time span between when symptoms were first noticed by patients or their family members, to their dementia diagnosis. 'We decided to examine the average interval between symptom onset and final diagnosis of dementia because this timeframe has significant implications for patient outcomes, families, and the overall healthcare system,' Orgeta said. 'Despite increasing awareness, many individuals still face delays of months or even years before receiving a formal diagnosis,' she said. 3.5 years for a dementia diagnosis once symptoms beginAt the study's conclusion, researchers found that dementia diagnosis occurs, on average, about 3.5 years after symptoms begin to show. This timespan average jumped to 4.1 years for participants with early onset dementia. 'The finding that it typically takes 3.5 years to receive a dementia diagnosis — and even longer, 4.1 years, for those with early-onset dementia — highlights a critical delay in the diagnostic journey, during which individuals and their families may be living with uncertainty, and without access to the support and planning resources they need.'— Vasiliki Orgeta, PhD'These findings underscore the urgent need to improve public awareness, enhance training for healthcare providers, and streamline referral pathways,' Orgeta said. Younger age, frontotemporal dementia linked to longer diagnosis timeOrgeta and her team also discovered that participants with a younger age at symptom onset and those diagnosed with frontotemporal dementia correlated with a longer diagnosis time. 'These delays mean that many younger individuals are left without the clarity, support, or medical care they need for years,' Orgeta said. 'Our findings emphasize the need for greater awareness and education among healthcare professionals to recognize the early signs of less common dementias, particularly in younger populations. Improving early detection in these groups is essential to ensure timely support, reduce misdiagnoses, and improve long-term outcomes.' 'We plan to work closely with people affected by dementia and their families, clinicians and policymakers to develop strategies that support earlier identification and more efficient diagnostic pathways — particularly for younger individuals and those with less common forms of dementia like frontotemporal dementia,' she added. What causes a delay in dementia diagnosis? MNT also spoke with Adel Aziz, MD, FAAN, cognitive and behavioral neurologist, assistant professor of neurology at Hackensack Meridian School of Medicine, and memory specialist at JFK University Medical Center, about this study. 'I would like to stress that experienced clinicians rarely find the concept of delayed dementia diagnosis surprising,' Aziz commented. 'What this meta-analysis adds is a shared language — 'Time To Diagnose (TTD)' — and empirical weights for each contributing factor. By translating anecdotes into measurable variables, it empowers specialists to benchmark performance, tailor interventions, and advocate for policy change.' Aziz explained that delays in diagnosing dementia arise at multiple points: when patients and families postpone seeking help, when primary providers hesitate to refer, and when early cognitive symptoms are misattributed to aging or anxiety.'This multifaceted issue intertwines with social determinants like education, socioeconomic status, minority identity, sex, age of symptom onset, dementia subtype, and the strength of a patient's support system,' he help lower the time between first dementia symptoms and formal diagnosis, Aziz said it will require community awareness campaigns to demystify dementia signs across diverse populations, provider education programs to train frontline clinicians on early, atypical dementia presentations, policy and advocacy to advocate for insurance coverage of cognitive assessments, and new technologies such as a telehealth cognitive screening for remote areas. 'With these layers of action — spanning public education, clinical training, policy reform, and technological innovation — we can move toward a future where dementia is recognized and managed as early as possible,' he added.
